Actium Biosystems LLC is categorized under Testing Laboratories in Boulder, CO and active since 2010.
Actium Biosystems LLC was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Testing Laboratories business, which does work in the B2B market, and is classified as a Testing Laboratories, under code number 541380 by the NAICS.
If you are seeking more information, feel free to contact George Kauss at the company’s single location by writing to 7007 Winchester Circle # 140, Boulder, Colorado CO 80301 or by phoning (303) 217-7722. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Actium Biosystems LLC |
| Contact Person: | George Kauss |
| Address: | 7007 Winchester Circle # 140, Boulder, Colorado 80301 |
| Phone Number: | (303) 217-7722 |
| Website Address: | actiumbiosystems.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Testing Laboratories |
| SIC Code: | 8734 |
| NAICS Code: | 541380 |
| Share This Business: |
Actium Biosystems LLC was started in 2010 to provide professional Testing Laboratories under the SIC code 8734 and NAICS code 541380. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact George Kauss for inquiries that concern Actium Biosystems LLC by calling the company number (303) 217-7722, as your correspondence is most welcome. Additionally, the physical location of the single location of Actium Biosystems LLC can be found at the coordinates 40.078519,-105.190645 as well as the street address 7007 Winchester Circle # 140 in Boulder, Colorado 80301.
For its online presence, you may visit Actium Biosystems LLC’s website at actiumbiosystems.com and engage with its social media outlets through on Twitter and on Facebook.